Gemseek
  • Company
    • About us
    • Careers
    • Leadership
    • Partnerships
  • How We Help
    • Predictive NPS (Predictive Net Promoter Score)
    • Vulnerable Customer Experience
    • Customer Experience Impact
    • Accelerating Analytics
  • Industries
    • Healthcare
    • Telecommunications
    • Consumer Goods
    • Insurance
    • Financial Services
  • Capabilities
    • CX Platform, customer experience platform, CX impact, CX analytics
    • Text Analytics
    • Advanced Analytics
    • Market Research
  • Resources
    • Success Stories
    • Blog
    • The CX Impact Podcast
  • Get in Touch
    • Subscribe for newsletter
August 17, 2022August 17, 2022Zoritsa Pencheva

Alzheimer’s Association International Conference: Competitive Brand Buzz Analysis

Gemseek

Online analysis based on AAIC22 mentions in the period 19 July – 7 Aug 2022

31 Jul – 4 Aug 2022

The Alzheimer’s Association International Conference® (AAIC®) 2022 is the premier annual forum for presentation and discussion of the latest Alzheimer’s and dementia research. This year’s hybrid conference event took place both virtually and in-person in San Diego and attracted over 9,500 attendees and more than 4,000 scientific presentations.

New research reported at the AAIC 2022 covered the breadth of Alzheimer’s and dementia research, including the basic biology of aging and the brain, risk factors and prevention strategies, and caregiving and living well with the disease.

Activity Over Time:

Brand Buzz:

24%

19%

14%

9%

6%

DEMENTIA

MEDICATIONS & TREATMENTS

DIAGNOSTICS

BIOMARKERS

ONGOING CARE

38%

9%

6%

9%

6%

“Biomarkers” includes all announcements of related research and studies, such as synaptic proteins, neurofilament light chain, etc.

For the purposes of this analysis, we measured mentions of Roche and their NeuroToolKit in a separate topic. It has a 2% and 1% share of categorized mentions on LinkedIn and Twitter, respectively.

“Ongoing care” includes all conversations about novel or established methods that help diagnosed patients maintain a good quality of life.


Relative shares are calculated out of all categorised posts within the respective social media.

Competitive Brand Buzz:

logo infographic-AAIC22-BrandBuzz

Influencers & Online Buzz Strategies:

What did the highest-ranking companies in Brand Buzz analysis talk about? Click on the three dots below to flip between tabs.

INFLUENCER & INDUSTRY

CAMPAIGN & PITCH

  • Roche-owned Genentech presented an overview of two decades of research of different treatments, including a blood-based biomarker test to aid in the detection of people with amyloid pathology.

INFLUENCER & INDUSTRY

CAMPAIGN & PITCH

  • Eisai presented their latest research on biomarkers for early diagnosis and treatments of Alzheimer or dementia patients. Their booth featured an interactive screen, named “The Growing Hope in Alzheimer’s Disease Experience.”

INFLUENCER & INDUSTRY

CAMPAIGN & PITCH

  • One of the key highlights of Eli Lilly's participation was a presentation about team-based approaches to timely and accurate diagnosis of Alzheimer’s Disease.

TOP 10 Influencers by Conversation Impact:

INFLUENCER:

FOLLOWERS:

  • 1

Phyllis (Barkman) Ferrell

Global Head, External Engagement, Alzheimer’s and Neurodegeneration at Eli Lilly and Company

eli lilly

7485

1276

  • 2

Yakeel T. Quiroz, PhD

Associate Professor of Psychiatry and Neurology at Massachusetts General Hospital

Harvard Medical School

1337

7063

  • 3

Bruce Lamb

Executive Director, Stark Neurosciences Research Institute at Indiana University School of Medicine

Indiana University School of Medicine

1313

1655

  • 4

Wiesje van der Flier

Scientific director at Alzheimer Center Amsterdam, Neuropsychologist, Clinical epidemiologist, PI Amsterdam Dementia Cohort, PI ABOARD-project

Amsterdam UMC - Alzheimer Center Amsterdam

1915

n/a

  • 5

Giulio Maria Pasinetti, MD, PhD

Saunders Family Chair and Professor of Neurology at the Icahn School of Medicine at Mount Sinai

Icahn School of Medicine at Mount Sinai

500

n/a

  • 6

Benedict C. Albensi, PhD, BCMAS, CRQM

Chair & Professor, Pharmaceutical Sciences. Co-director B.R.A.I.N., Clinical Trials PI, Neuroscientist, Alzheimer’s Disease, Editor-in-Chief of Molecular Neurobiology

Nova Southeastern University- College of Pharmacy

10541

2111

  • 7

Brittany Cassin, MBA

My Every Day is Committed to Brain Health | Emerging Technology Commercialization Leader

NIA Small Business Programs

2352

37

  • 8

Heleen M. A. Hendriksen

PhD student | Neuropsychologist bij Amsterdam UMC – Alzheimercentrum Amsterdam

Amsterdam UMC - Alzheimer Center Amsterdam

627

87

  • 9

Bryan James

Associate Professor at Rush University Medical Center

Rush University Medical Center

442

1340

  • 10

Malú Gámez Tansey

Norman and Susan Fixel Professor and Co-Director Center for Translational Research in Neurodegenerative Research (CTRND)
Nature Portfolio

2238

5364

Top Buzz-Generating Posts:

Studying #AlzheimersDisease takes perseverance, but that commitment is worth the effort when you remember who it’s for: The people living with the disease and those who love them. #AAIC22

— Eli Lilly and Company (@LillyPad) July 31, 2022

Curious to know more about the AAIC22 Brand Buzz?

GET IN TOUCH WITH US

Latest Resources

blog cover-03
Creating Value for the Customers, With the Customers
read more
Radiology Department Staff Shortage_article banner
Radiology Department Staff Shortage: Key contributing factors and how to address them
read more
Brand Buzz RSNA 2022_banner image
RSNA 2022 Competitive Brand Buzz Report
read more

Follow us:

See what’s new. Sign up for our newsletter:

Subscribe now

Post navigation

← Healthcare Insights – August 2022
Leading Telecom Operator Understands Customer Pain Points in Greater Detail With Text Analytics →

How We Help

  • Profitable Customer Growth
  • Customer Experience Impact
  • Accelerating Analytics
  • Marketplace Optimisation

Industries

  • Telecommunications
  • Healthcare Draft
  • Consumer Goods

Resources

  • Success Stories
  • Blog
  • The CX Impact Podcast

Gemseek is a leader in Experience Management on G2

Contact

-359-02-203910

18 Shipchenski Prohod Blvd.,
Office 701, Sofia 1113, Bulgaria

-359-02-203910

30 Stamford Street,
SouthBank, London, SE1 9PY, UK

-359-02-203910

125E J. Geesinkweg, 4th fl.,
1096 AT Amsterdam, The
Netherlands

-359-02-203910

Latimer House,
Langford Business Park,
Kidlington, OX5 1GG, UK

-359-02-203910

Discovery House,
Aveling Road, High Wycombe,
HP13 6AE, UK

-359-02-203910

6 rue de Saint Petersbourg,
75008 Paris, France

-359-02-203910

Office 2302
Building 3 - JLT Cluster X
Jumeirah Lakes Towers
P.O.Box 454566
Dubai, UAE

  • Privacy Policy

Copyright © 2021 Gemseek. All Rights Reserved.

Copyright NPS® is a registered trademark, and Net Promoter Score℠ and Net Promoter System℠ are service marks, of Bain & Company, Inc., Satmetrix Systems, Inc. and Fred Reichheld.